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Aging is associated with a progressive loss of muscle mass and strength and a decline in
neurophysiological functions. Age-related neuromuscular junction (NMJ) plays a key role
in musculoskeletal impairment that occurs with aging. However, whether changes in the
NMJ precede or follow the decline of muscle mass and strength remains unresolved.
Many factors such as mitochondrial dysfunction, oxidative stress, inflammation, changes
in the innervation of muscle fibers, and mechanical properties of the motor units probably
perform an important role in NMJ degeneration and muscle mass and strength decline in
late life.This review addresses the primary events that might lead to NMJ dysfunction with
aging, including studies on biomarkers, signaling pathways, and animal models. Interven-
tions such as caloric restriction and exercise may positively affect the NMJ through this
mechanism and attenuate the age-related progressive impairment in motor function.
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INTRODUCTION
Autopsy studies in persons who died of acute trauma while rela-
tively healthy have shown that aging is associated with a gradual
loss of motor neurons (Valdez et al., 2010; Rowan et al., 2012).
The mechanism that leads to neuronal loss with aging is still
unclear and may involve both impaired trophic signaling from
the central nervous system (CNS), local degeneration, and feed-
back from dysfunctional muscle. Indeed, individuals over 65 years
of age exhibit reduced activity in motor brain areas, increased
oxidative stress in motor neurons and impaired energetic metab-
olism in muscle fibers (Deschenes et al., 2010; Ferrucci et al., 2012;
Reid et al., 2012, 2014; Manini et al., 2013). However, there is evi-
dence that this decrease in muscle energetic metabolism is not
solely affected by aging but also by the levels of physical activity,
suggesting that energetic changes are more likely to be a func-
tion of activity, and not time (Tevald et al., 2010; Russ and Lanza,
2011).
Regardless of the cause, when a motor neuron is lost, fibers
previously innervated by that neuron, globally defined as a motor
unit, are no longer controlled by the nervous system and fail
to contribute to the force generated during a volitional muscle
contraction. In the attempt to counteract the functional conse-
quence of this process, denervated orphan fibers express proteins
and produce chemotactic signals that stimulate the sprouting of
new dendrites from residual motor neurons. This process leads
re-innervation by the expansion of pre-existing motor units and
is aimed at returning to function previously denervated muscle
fibers. This dynamic denervation–re-innervation cycle success-
fully compensates for neuronal loss, with little decline in global
strength and only slightly reduced control. However, there is evi-
dence that this compensatory mechanism starts failing with aging.
Some denervated fibers are not successfully re-innervated, become
apoptotic, and are not replaced by new fibers. It is hypothesized
that this phenomenon contributes to a progressive decline in
muscle mass and strength with aging.
The reason for a progressive impairment of the re-innervation
process with aging is unknown, but some lines of evidence point
to changes that occur with aging in the neuromuscular junction
(NMJ), which is the synaptic interface between a branch of a motor
neuron and muscle cells. The NMJ is composed of three elements:
pre-synaptic (motor nerve terminal), intrasynaptic (synaptic basal
lamina), and post-synaptic part (muscle fiber and muscle mem-
brane) (Punga and Ruegg, 2012). When an action potential reaches
the pre-synaptic element, voltage-dependent calcium channels
open allowing calcium to enter the neuron and trigger the deliv-
ery of acetylcholine (ACh) in the synaptic cleft. Acetylcholine
triggers nicotin acetylcholine receptors (nAChR) located in the
post-synaptic membrane to produce an action potential, which in
turn, activates voltage-gated dihydropyridine receptors (DHPRs)
located in the sarcolemma and by induction, ryanodine receptors
(RyRs). Of note, the post-synaptic membrane presents folds that
expand its area. Calcium released from the sarcoplasmic reticulum
through the RyRs binds to troponin C and allows cross-bridge
cycling and force production (Figure 1).
Over the last decade, age-associated degeneration of the NMJ
has been reported. It has been proposed that such changes may be
causally related to the decline in muscle mass and function that
occurs in most aging individuals. However, whether changes in the
NMJ precede or follow the decline of muscle mass and strength
remains unresolved. Understanding whether the primary event
in the pathway to sarcopenia is muscle denervation, NMJ frag-
mentation or muscle fiber degeneration is important because the
identification of the source of the primary event influences strate-
gies to delay the onset of age-related muscle dysfunction. In this
report, we review our current understanding of the events that lead
to NMJ dysfunction with aging, including studies on biomarkers,
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FIGURE 1 |The architecture of a neuromuscular junction (NMJ).
(A, B)The NMJ is composed of three elements: pre-synaptic (motor nerve
terminal), intrasynaptic (synaptic basal lamina), and post-synaptic
component (muscle fiber and muscle membrane) (Punga and Ruegg, 2012).
When the action potential reaches the motor nerve terminal the calcium
channels open and the calcium enters in the neuron and delivers ACh in the
synaptic cleft. (C) AChR activates the DHPRs located in the sarcolemma and
by induction the RyRs. Calcium released from the sarcoplasmic reticulum
through the RyRs binds to troponin C and allows cross-bridge cycling and
force production.
signaling pathways, and animal models. We propose that interven-
tions aimed at preventing the deterioration of the NMJ should be
aimed at reversing the mechanisms that lead to NMJ degeneration
with aging. It is important to underline that our comprehension
of the global mechanism that lead to NJM impairment with aging
is still patchy. Some of the elements emerging in the literature will
be described and their relationship with aging explored. How-
ever, it is worth noticing that how these different parts participate
and interact within a unique global mechanism and cause NMJ
dysfunction with aging is not understood.
THE AGED NEUROMUSCULAR JUNCTION
CHANGES THAT OCCUR WITH AGING IN THE NMJ
The structure of the NMJ varies depending on the muscle
fiber innervated and potentially on the level of muscle activity
(Smith and Rosenheimer, 1982; Rosenheimer and Smith, 1985;
Arrowsmith, 2007). There is strong evidence that changes in end-
plate morphology and NMJ remodeling occur with aging and
precede loss of fast motor units. Morphologically, both the nerve
terminal area and the number of post-synaptic folds are reduced
leading to a functional impairment in the post-synaptic response
of the NMJ (i.e., motor nerve conduction velocity becomes slower
and the amplitude of compound muscle action potential (CMAP)
decreases) (Kurokawa et al., 1999). Mitochondria in the plaque
region are numerically reduced and tend to show signs of degen-
eration. In particular, some authors have described dramatic alter-
ations in mitochondrial morphology in axon terminals, including
cristae disruption, swelling, and formation of megamitochondria
due to multiple fusions between adjacent mitochondria (Garcia
et al., 2013). Studies of pre-synaptic plaque changes with aging
have found high levels of oxidative damage, decreased number
of synaptic vesicles, and lower quantities of neurotransmitter
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released during depolarization (Figure 2). These changes have
been correlated with denervation of muscle fibers and muscle
atrophy occurring in a fiber dependent manner (Banker et al.,
1983; Jang and Van Remmen, 2011; Rowan et al., 2012). Hypoth-
esized mechanisms include (1) progressively reduced capacity of
motor neurons to re-innervate muscle fibers that are denervated or
regenerating; (2) impaired excitation–contraction coupling; and
(3) age-associated decline in satellite cell proliferation (Clark and
Fielding, 2012; Rosso et al., 2013) (Figure 3). In particular, Clark
and Fielding (2012) suggest that the NMJ activation of muscle
agonists is impaired in some older adults in whom weakness is
more prominent than reduced muscle mass.
As mentioned previously, some studies (Li et al., 2011) suggest
that in mice,NMJ changes follow degeneration and regeneration of
individual muscle fibers, while others suggest that muscle denerva-
tion might be a consequence of high energetic demand in skeletal
muscle fibers, as found in human mutant SOD1 (mSOD1) mice
who develop amyotrophy and muscle denervation (Dupuis et al.,
2004, 2009, 2011).
Mitochondrial dysfunction and oxidative stress in NMJ dysfunction
Mitochondria play a critical role in regulating energy production,
metabolism, signal transduction, and apoptosis and are also the
primary source of oxygen free radicals generated by the dislocation
of electrons traveling across the respiratory chain (Peterson et al.,
2012). The numerous mitochondria in the axon not only provide
energy but also buffer the large calcium ion loads which are essen-
tial for excite–contraction coupling (Barrett et al., 2011). Decline
in number and function of mitochondria as well as frequent
modification of their morphological structure with aging has been
described in many tissues, including skeletal muscle. Dysfunc-
tional mitochondria are often found with aging, characterized
by increased levels of oxidation and nitrosylation products and
decreased enzymatic activity. It has been hypothesized that the
diffusion of mitochondrial nitric oxide (NO) and hydrogen per-
oxide (H2O2) to the cytosol is decreased in the aged brain and may
impair mitochondrial biogenesis (Navarro and Boveris, 2009).
Since neurons and muscle fibers are highly metabolically active,
it is rational to hypothesize that they are affected by even minor
mitochondrial dysfunction (Li et al., 2013; Baines et al., 2014).
Indeed, it has been recently shown in sarcopenic rats with NMJ
disruption that the expression of genes implicated in mitochon-
drial energy metabolism is down regulated (Ibebunjo et al., 2013).
However, the role of oxidative stress in peripheral nervous system
aging and pathology remains poorly understood (Lin and Beal,
2006; Garcia et al., 2013). Reduced ATP production and impaired
calcium buffering in the subsarcolemmal mitochondria located
near the NMJ may impair both neurotransmission and vesicular
recycling (Deschenes, 2011).
Changes in the innervation of muscle fibers and motor units
Neuron loss (cell death) that occurs with aging is progressive and,
as far as we know, irreversible. Loss of motor units in young adults
results in re-innervation of denervated fibers by sprouting from
other motor neurons and in death of fibers that are not success-
fully re-innervated. The details of this process have been studied
mostly in animal models. Chai et al. (2011) have shown that in
mice, while the size and number of alpha motor neurons in the
FIGURE 2 | Primary causes of NMJ dysfunction during aging. Factors such as mitochondrial dysfunction, oxidative stress, inflammation, and changes in the
innervation of muscle fiber and mechanical properties of the motor units could play an important role in the NMJ degeneration and development of sarcopenia.
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FIGURE 3 | Changes in the neuromuscular junction with aging. Structural changes together with functional alterations result in a NMJ impairment during
aging. The excitation–contraction uncoupling leads to a loss of communication between the nervous and muscular system, causing a decline in skeletal muscle
strength and muscle mass.
spinal cord do not change until very late in life, profound earlier
change is observed at the NMJ. In very late life, motor neurons
show impaired capacity to sprout and re-innervate denervated
fibers, and as a consequence, larger motor units become smaller,
and more fatigable and there is a considerable atrophy of muscle
fibers (Luff, 1998; Roubenoff, 2000; Glass and Roubenoff, 2010).
Macroscopic age-associated muscle atrophy is due to a combina-
tion of individual fiber atrophy and a decrease in the total number
of type II fibers (fast and glycolytic muscle fibers) (Lexell, 1995,
1997; Andersen, 2003; Suetta et al., 2012). These alterations in
morphologic remodeling in the aged NMJ result in more dis-
persed AChR, with greater spatial uncoupling between ACh vesicle
clusters and receptor clusters. These events together induce phys-
iological adaptations (i.e., changes of a quantal level) in the aged
NMJ that have been extensively reviewed by Deschenes (2011).
According to current views, Schwann cells (cells that myeli-
nate axons) play an critical role in synaptic repair following
denervation, through their ability to direct axonal regrowth, re-
myelinate, and allow functional recovery by secreting trophic and
growth factors (Rangaraju et al., 2009; Rangaraju and Notter-
pek, 2011; Kim et al., 2013). Impairment in these cells, such as
increased fragmentation, damage, or denervation may contribute
to ineffective re-innervation and neuromuscular dysfunction in
aging (Verge et al., 1996; Kawabuchi et al., 2001, 2011; Gordon
et al., 2009).
Changes that occur at the NMJ with aging are paralleled by a
progressive uncoupling of the excitation–contraction in the skele-
tal muscle (Delbono et al., 1995, 1997; Delbono, 2003). It has
been hypothesized that age-related muscle uncoupling is due to
a mismatch between DHPR and RyR. In particular RyR would
be more numerous than DHPR. This uncoupling reduces calcium
release after an action potential, resulting in less efficient con-
traction (Wang et al., 2004; Shear and Martyn, 2009). It has been
shown that insulin-like growth factor-I (IGF-1) could prevent the
age-related decline in the number of DHPRs, therefore prevent-
ing the changes in nerve terminal and NMJ (Delbono, 2000, 2003;
Zheng et al., 2002). These findings suggest that overexpression of
IGF-1 may have a role in preventing muscle strength decline with
aging.
Inflammation in aging (inflammaging)
Aging is characterized by high circulating levels of inflammatory
markers such as interleukin 6 (IL-6), interleukin 1 (IL-1), tumor
necrosis factor alpha (TNF-alpha), and C-reactive protein (CRP)
in blood and tissues, often without a clear cause. This chronic
low-grade inflammation in older persons has been defined by
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Franceschi et al. (2007) as “inflammaging.” Epidemiological stud-
ies have consistently demonstrated that “inflammaging” is a risk
factor for accelerated decline of muscle mass and strength with
aging, and that these changes in muscle performance may be a crit-
ical mediating step in the causal pathway between “inflammaging”
and mobility disability (Ferrucci et al., 1999, 2005). In addition,
medical conditions characterized by chronic overt inflammation
often cause muscle wasting and weakness (Saini et al., 2007, 2009;
Degens, 2010; Ferrucci et al., 2013). The mild pro-inflammatory
state of aging may affect muscle performance and maintenance in
many ways. For example, Schwann cell senescence has been associ-
ated with overexpression of IL-6, suggesting a role of inflammation
in the age-related alterations in axonal regeneration (Saheb-Al-
Zamani et al., 2013). Chronic inflammation down regulates the
production of IGF-1 and blunts its biological activity. Inflamma-
tion is associated with impaired amino acid (Aa) utilization and
protein anabolism, especially in critical periods such as after a meal
or after a bout of exercise.
BIOMARKERS OF NMJ IN AGING AND SIGNALING
PATHWAYS
The direct study of the NMJ in human beings presents challenges
that are almost insurmountable. The NMJ is seldom detected in
muscle needle biopsies and requires open surgery biopsies that
are only done for diagnostic purposes. Newly emerging neuro-
physiological techniques may be used in the future to study the
NMJ but they are still at an early stage of development. One of
the most promising areas of investigation and perhaps the one
with the strongest translational potential is the study of circu-
lating biomarkers, such as neurotrophic factors, muscle anabolic
hormones, and growth factors that are known to have a role in
NMJ dysfunction. Although most of the biomarkers addressed in
this section are known to change with aging, whether they modu-
late the causal pathway from aging to NMJ impairment with aging
is not fully established. Nevertheless, correlational studies may
provide knowledge that in the future may help reconstructing a
general model of the mechanism leading to NMJ degeneration
with aging.
NEUROTROPHIC FACTORS
Neurotrophins are a family of proteins implicated in neural devel-
opment, maintenance, and maturation that also play a role in
neurotransmission. Changes in production and response to neu-
rotrophins with aging may contribute to reduced axonal regener-
ation, and dysfunction at multiple levels, including motor axons,
post-synaptic membrane, and Schwann cells. One of the most
studied neurotrophic factors is brain-derived neurotrophic fac-
tor (BDNF), which plays a critical role in neural plasticity and
facilitates synaptic function by increasing pre-synaptic depolar-
ization at the NMJ (Seeburger and Springer, 1993; Springer et al.,
1995; Huang and Reichardt, 2001; Lipsky and Marini, 2007; Jiang
et al., 2008; Gomez-Pinilla, 2011) and maintaining AChR clus-
tering in the NMJ (Gomez-Pinilla et al., 2002; Peng et al., 2003).
Interestingly, there is some initial evidence that production of glia
cell-derived neurotrophic factor (GDNF) declines with aging (Li
et al., 1995). Denervation leads to an up regulation of GDNF in
rat and human skeletal muscle (Lie and Weis, 1998). Consistently,
in vitro studies have found that GDNF is a potent trophic factor
for motor neuron survival and a potent regulator of pre- and post-
synaptic plasticity (Lin et al., 1993; Nguyen et al., 1998). Moreover,
GDNF protein content in aged rat skeletal muscle might be con-
trolled by stretching the muscle and the membrane depolarization
of AChR acts to decrease GDNF protein content (McCullough
et al., 2011).
There is evidence that short-term exercise increases levels of
GDNF in the skeletal muscle and spinal cord of young and old rats
(McCullough et al., 2013). Gyorkos et al. (2014) found increased
GDNF protein levels at the end plate in the soleus and extensor
digitorum longus muscles following training, supporting the idea
that GDNF is activity dependent. Different models of exercise type
and intensity could have varying effects on GDNF protein content
in slow- and fast-twitch muscle fibers. The authors concluded that
GDNF may play a role in remodeling of the NMJ in slow and
fast-twitch muscle fibers.
INSULIN-LIKE GROWTH FACTOR 1
Insulin-like growth factor 1 is a pleiotropic growth factor with
many functions, including a neutrotrophic effect, promotion of
motor neuron survival, maintenance of muscle mass and strength,
and protection from oxidative stress (Yuan et al., 2000; Maggio
et al., 2006, 2013; Apel et al., 2010). Many studies have found
that circulating IGF-1 declines with aging and such decline may
contribute to NMJ degeneration and motor unit denervation
(Delbono, 2003; Messi and Delbono, 2003). In accordance with
this hypothesis, in mouse models, the overexpression of muscle-
specific IGF-1 reverses sarcopenia (Musaro et al., 2001), prevents
the age-dependent decrease in type IIB and increase in type IIA
fibers (Messi and Delbono, 2003), and also leads to improved nerve
regeneration by acting on axons, Schwann cells, and the NMJ. Sys-
temic administration of IGF-1 decreased motor neuron cell death
and promoted muscle re-innervation after injury in young ani-
mals, suggesting that the decline in IGF-1 with aging may impair
the ability of aging animals to repair and maintain the integrity of
NMJ (Vergani et al., 1998). IGF-1 sensitivity may not decrease with
age, so that IGF-1 could promote regeneration after nerve injury
even in older individuals. Overexpression of muscle-specific IGF-
1 in mice increases the size of NMJ without substantial changes in
muscle fiber size suggesting that preservation of specific force in
aged animals overexpressing IGF-1 in muscle is achieved, in part,
by improved motor neurons-muscle coupling (Payne et al., 2006).
AGRIN-MuSK SIGNALING PATHWAY
Acetylcholine receptors clustering on the post-synaptic membrane
is a main event in the differentiation of NMJ. This process requires
the presence of neural agrin, a basal lamina proteoglycan that acti-
vates a muscle-specific kinase (MuSK), which is essential for AChR
clustering.
Agrin is transported along the axons and finally released into
synaptic basal lamina where it is inactivated by cleavage from neu-
rotrypsin, a synaptic protease, which produces a soluble 22 kDa
C-terminal agrin fragment (CAF). Importantly, CAF can be eas-
ily detected and measured in human serum (Bolliger et al., 2010;
Butikofer et al., 2011). The destabilization of the NMJ by pro-
teolysis of agrin results in precocious sarcopenia (Drey et al.,
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2013; Hettwer et al., 2013). This is consistent with findings in
experiments with transgenic mice overexpressing neurotrypsin
in spinal motoneurons that shown the full sarcopenia phenotype
(Butikofer et al., 2011).
Wnt SIGNALING PATHWAY
There is wide evidence, both in animals models and in humans,
the Wnt signaling pathway is down regulated with aging and con-
tributes to the progressive reduction in muscle regeneration and
repair capacity (Conboy and Rando, 2012). Wnt proteins are a
large family (19 members in humans) of secreted glycoproteins
that are highly evolutionary conserved. Wnt signaling modu-
lates the formation and the function of synapses and is involved
in maintenance and function of many tissues including muscle
and nerve. Wnt deregulation produces many neurodegenerative
and mental diseases (Okerlund and Cheyette, 2011; Mulligan and
Cheyette, 2012; Stamatakou and Salinas, 2013).
The role of WNT signaling on the NMJ is complex. Canoni-
cal and non-canonical Wnt pathways exert opposite effects on the
formation of the vertebrate NMJ (Korkut and Budnik, 2009). The
non-canonical Wnt cascade has a positive role on post-synaptic
development. In contrast, activation of the canonical Wnt path-
way has a negative effect on NMJ formation. Thus, while the role
of Wnt signaling on NMJ development and in muscle regener-
ation impairment with aging is well established, evidence for a
direct effect of Wnt on NMJ plasticity, maintenance, and repair is
lacking and requires further investigation.
VOLTAGE-GATED SODIUM CHANNEL: Nav1.5
The Nav channel gene family (Nav1.1–Nav1.9, NaVX) codes for
voltage-gated sodium channels (NaChs), which are essential for
the initiation and propagation of action potentials in both nerve
and muscle (Young and Caldwell, 2005). Adult skeletal muscle
expresses two isoforms of Nav (Nav1.4 and Nav1.5) (Rannou
et al., 2011; Kraner et al., 2012). The isoform Nav1.5 is particularly
relevant to aging because it is mainly expressed in adult muscle
following denervation (Kallen et al., 1990; Morel et al., 2010).
Consistently, fibers positive for tetrodotoxin resistant (TTX-R)
Nav1.5 channels are more prevalent in muscles from old compared
with young mice, suggesting a potential biomarker for muscle
denervation during aging (Wang et al., 2005; Rowan et al., 2012).
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA
COACTIVATOR 1-ALPHA (PGC-1α)
Peroxisome proliferator-activated receptor gamma coactivator 1-
alpha (PGC-1α) is a transcription factor that promotes mito-
chondrial biogenesis. Studies have consistently shown that PGC-
1α decline with aging and in many age-related chronic dis-
eases suggesting that such decline may explain the progressive
mitochondrial dysfunction with aging.
Recent studies using muscle-specific PGC-1α knockout and
PGC-1α overexpressing mice have suggested that PGC-1α is a key
protein involved in NMJ integrity, and the decline in PGC-1α
may cause NMJ degeneration with aging by a mechanism that is
separate from the effect of PGC-1α on mitochondrial biogenesis
(Handschin et al., 2007; Wenz et al., 2009; Liang et al., 2011; Gous-
pillou et al., 2013). There is recent strong evidence that elevated
activity of the co-activator PGC-1α in skeletal muscle contributes
to the efficient pre- and post-synaptic remodeling of the NMJ
(Arnold et al., 2014).
Gouspillou et al. (2013) hypothesized that the denervation and
innervation cycle observed with aging is under the control of
PGC-1α expression and proposed that the aging-related decline
in PGC-1α may be a central mechanism promoting instability of
the NMJ and consequently aging-related alterations of myofiber
innervation in sarcopenia. Interestingly, the decline in muscle
PGC-1α levels with aging is attenuated by caloric restriction (CR)
and exercise (Derbre et al., 2012; Garcia-Valles et al., 2013).
PROTEIN DEGRADATION PATHWAYS: MAFbx AND MuRF1
The ubiquitin–proteasome and the autophagic-lysosomal path-
ways are activated during disease-related muscle atrophy and,
perhaps, during the development of age-related sarcopenia. The
ubiquitin–proteasome system is required to remove sarcomeric
proteins, either because they are damaged or in response to decline
in muscle activity. Two main enzymes at the core of this system,
the ubiquitin ligases muscle atrophy f-box (Atrogin1/MAFbx) and
muscle ring finger-1 (MuRF1), increase significantly in muscular
atrophy, in part due to enhanced expression of tumor necrosis
factor alpha (TNF-α). Mice lacking both are resistant to atrophy
induced by denervation (Bodine et al., 2001; Lecker et al., 2004;
Nordquist et al., 2007; Furlow et al., 2013). There is some evi-
dence that MuRF1 could play a role in NMJ control by regulating
AChR lifetime, implicating a role of MuRF1 in membrane pro-
tein turnover during aging (Rudolf et al., 2013; Franke et al., 2014;
Khan et al., 2014).
THE STUDY OF NMJ IN AGING: ANIMALS MODELS
The NMJ is the best model to study synaptogenesis, because, at
least in animals, it is experimentally accessible in a living organ-
ism. The mechanisms that lead to differentiation and maturation
of the NMJ have been studied extensively while changes that occur
with aging and lead to impairment of the NMJ are not fully under-
stood. Most of the studies conducted in this field focused on early
development (i.e., the KO mice for synaptic regulators such as
rapsyn, agrin, MuSK, and AChR) (Yampolsky et al., 2010; Witze-
mann et al., 2013). Mouse models that were originally developed
to study neuromuscular diseases [i.e., amyotrophic lateral sclerosis
(ALS)] could be used to explore the effect of aging on the NMJ.
The prototype of these models is the Sod1-/- mice.
Sod1-/- MICE
The homozygous deletion of Cu/Zn superoxide dismutase (Cu/Zn
SOD) leads to age-dependent muscle atrophy with alterations in
NMJ similar to, but more severe than aging-related muscle atro-
phy (Sakellariou et al., 2011, 2014). This model is of great interest
because the main function of SOD is to scavenge free oxygen
radicals, being the oxidative stress, one of the landmarks of aging.
The Sod1-/- mice were originally created to study ALS and
addresses pathological events in the spinal cord, peripheral axons,
and muscle. However, the neuromuscular sarcopenic pheno-
types exhibited by this mouse share several characteristics with
age-related sarcopenia, namely shift from fast to slow fiber type,
mitochondrial dysfunction, and increased mitochondrial ROS
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generation (Jang and Van Remmen, 2009, 2011). In particular,
the mitochondrial dysfunction might contribute to early motor
terminal death in these mice (Muller et al., 2007). Rocha et al.
(2013) have shown that the Sod1-/- mice undergo cycles of
denervation/re-innervation by mixed NMJ populations (Sod1a,
Sod1b) supporting morphological evidence for two populations
of motor units in Sod1-/- mice (Schaefer et al., 2005). All
together these data suggest that the impairment in neuromuscular
transmission follows post-synaptic changes.
MRF4-NULL MICE
Muscle regulatory factor 4 (MRF4) is a member of the family
of myogenic transcription factors (MyoD, myogenin, and myf-5)
necessary for the differentiation of skeletal muscle (Weis et al.,
2000). MRF4-null mice express genes encoding nAChR subunits
and contractile proteins at normal levels, but express myogenin at
dramatically increased levels. These mice have normal morphol-
ogy and fiber-type composition (Zhang et al., 1995) and reduced
expression of the Nav 1.4 NaCh (Snow et al., 2005). Denervation
leads to a rapid increase of MRF4 protein in myofiber and satellite
cell nuclei in all muscle fiber types, suggesting that MRF4 might
mediates the earliest responses to denervation and muscle dam-
age (Weis et al., 2000). The NMJs in these mice at older age show
higher levels of synaptic vesicle glycoprotein 2B (SV2B) a marker
of synaptic vesicles and a decrease in MRF4 expression, suggest-
ing an age-related loss of vesicles in the pre-synaptic terminal of
MRF4-null mice that could lead to NMJ dysfunction (Wang et al.,
2011). These authors propose MRF4 as a good therapeutic target
to restoring and maintaining NMJ in aging and diseases.
INTERVENTIONS TO IMPROVE NMJ DYSFUNCTION IN
AGING
Caloric restriction and exercise attenuate age-related declines in
most physiological systems including the neuromuscular system
(McKiernan et al., 2004; Gillette-Guyonnet andVellas, 2008;Valdez
et al., 2010; Mercken et al., 2012; Chistiakov et al., 2014). It has
been shown that CR, but not exercise, blunts age-related loss of
motor neurons and muscle fibers (Deschenes, 2011). Aging ‘per se’
limits the capacity of a person to adapt to an exercise training pro-
gram since muscle plasticity is reduced with aging (Degens, 2010).
Because the NMJ could be impaired during aging, with a reduced
capacity to adapt to fatigue, CR and exercise are candidate inter-
ventions to delay the onset of age-related NMJ dysfunction and
sarcopenia.
CALORIC RESTRICTION
Caloric restriction has long been shown to be the most effective,
non-genetic intervention to extend lifespan and delay the onset
of age-related diseases (McCay et al., 1935; Fontana et al., 2010;
Anderson and Weindruch, 2012; Gouspillou and Hepple, 2013).
Valdez et al. (2010) found that CR from 4 to 24 months of age led to
sparing of many NMJs in the tibialis anterior (TA) muscle in mice.
The frequencies of fragmented and denervated post-synaptic sites
were all significantly lower in these calorically restricted mice than
in controls. The authors concluded that CR reduced the incidence
of axonal atrophy and attenuated the deleterious effects of age on
the structure of the NMJ. Other authors have found that dietary
restriction (40% of ad libitum fed diet) attenuates age-associated
muscle atrophy by lowering oxidative stress in Sod1-/- mice and
up-regulating manganese superoxide dismutase (MnSOD), the
main mitochondrial antioxidant enzyme responsible for scaveng-
ing superoxide produced by the mitochondrial electron transport
chain (ETC). These data suggest that the CR model may be use-
ful to identify mechanisms and targets for interventions aimed at
preservation of NMJ with aging (Jang et al., 2012). Furthermore,
Mayhew et al. (1998) propose that CR preserves the mechanical
properties of aging skeletal muscles in rats through an increased
expression of DHPRs.
EXERCISE
Voluntary physical activity declines with aging in humans and in
most other animal species. The consequent reduction in fitness
leads to reduced resistance to fatigue, lower muscle strength, and
increased risk of frailty (Degens and Alway, 2006; Ferrucci et al.,
2008; Afilalo et al., 2014). Neuromuscular fatigue (progressively
impaired transduction of action potentials through the NMJ dur-
ing exercise) has been identified as a factor constraining exercise
intensity and duration, and a contributor to reduced response to
exercise training during aging (Belluardo et al., 2001; Deschenes,
2011). A recent review highlighted the beneficial effects of exercise
on the maintenance and regeneration of NMJs (Nishimune et al.,
2014). Exercise induces NMJ hypertrophy and improves recovery
from peripheral nerve injuries, while decreased physical activity
results in NMJ degeneration and nerve terminal sprouting (Wil-
son and Deschenes, 2005; Nishimune et al., 2012, 2014). Clark et al.
(2013) suggest that voluntary neuromuscular activation declines
with advancing age, contributing to a reduction in power produc-
tion, and precedes the decline of mobility function. Aging limit
the capacity of NMJ to adapt to endurance training (Deschenes
et al., 2010; Valdez et al., 2010). These findings suggest that in the
presence of mitochondrial DNA (mtDNA) mutation induced by
ROS, strength training (ST) can reverse the loss of muscle function
and altered muscle morphology associated with age and can pro-
mote the normalization of dysfunctional mitochondria (Hurley
et al., 2011). Voluntary running exercise begun in late middle-age
is sufficient to preserve much of the endplate nerve terminal area
(Cheng et al., 2013). In mice, endurance training reduced muscle
fiber size in young adults even as NMJ size increased (Deschenes,
2011). Also, in mice, Fahim (1997) showed that if the exercise
training is introduced during old age, the age-related expansion
of NMJ is minimized and modulated at a lower level compared
with sedentary controls, indicating that the mouse NMJ under-
goes a process of physiological and morphological remodeling
during aging, and such plasticity could be modulated differently
by endurance exercise.
CONCLUSION AND FUTURE DIRECTIONS
Age-related NMJ dysfunction seems to be a key to understand-
ing musculoskeletal impairment during aging. Morphological
changes together with physiological alterations result in a remod-
eling of the motor unit and in a decline of the number of motor
neurons, particularly the type II muscle fiber. These changes lead
to excitation–contraction uncoupling, and a loss of communica-
tion between the nervous and muscular system, causing a decline
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in skeletal muscle strength and muscle mass. Despite the extensive
evidence about muscle denervation in older persons, because the
direct study of NMJ in humans remains extremely challenging,
it remains unclear whether denervation precedes sarcopenia or
vice versa. Understanding the molecular basis of NMJ dysfunc-
tion is essential and the study of biomarker is essential both to
make scientific progress in this area and translating such research
in search for new treatment. Not only new structural and mole-
cular studies, but also novel animal models to clarify what really
happens to this key connection between brain and muscle are
needed.
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